Executive coaching outcome research: The contribution of common factors such as relationship, personality match, and self-efficacy.

E De Haan, A Duckworth, D Birch… - … Journal: Practice and …, 2013 - psycnet.apa.org
This article argues for a new way of studying executive coaching outcomes, which is
illustrated with a study based on data from 156 client–coach pairs. The argument accepts …

Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study

A Duckworth, MA Gibbons, RJ Allen… - The Lancet …, 2021 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease accounting for 1% of
UK deaths. In the familial form of pulmonary fibrosis, causal genes have been identified in …

[PDF][PDF] Signalling a new trend in executive coaching outcome research

E De Haan, A Duckworth - International Coaching Psychology …, 2013 - erikdehaan.com
Purpose: This contribution argues for a new way of studying executive-coaching outcome.
The argument accepts that we are not likely to get rigorous data on coaching outcome from …

[HTML][HTML] The role of herpes viruses in pulmonary fibrosis

A Duckworth, HJ Longhurst, JK Paxton… - Frontiers in …, 2021 - frontiersin.org
Pulmonary fibrosis (PF) is a serious lung disease which can result from known genetic or
environmental exposures but is more commonly idiopathic (IPF). In familial PF (FPF), the …

[HTML][HTML] Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic …

TA Mikolasch, PM George, J Sahota, T Nancarrow… - …, 2023 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder with a
variable disease trajectory. The aim of this study was to assess the potential of neutrophil-to …

[HTML][HTML] The MUC5B promoter polymorphism associates with severe COVID-19 in the European population

CHM van Moorsel, JJ van der Vis, A Duckworth… - Frontiers in …, 2021 - frontiersin.org
Diversity in response on exposure to severe acute respiratory syndrome coronavirus 2 may
be related to the innate immune response in the elderly. The mucin MUC5B is an important …

Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis

DLW Chong, TA Mikolasch, J Sahota… - … of Physiology-Lung …, 2023 - journals.physiology.org
Transforming growth factor-β1 (TGFβ1) is the key profibrotic cytokine in idiopathic pulmonary
fibrosis (IPF), but the primary source of this cytokine in this disease is unknown. Platelets …

Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib.

AB Blechman, CE Cabell, CH Weinberger… - Journal of drugs in …, 2017 - europepmc.org
The Food and Drug Administration approved Ruxolitinib in 2011 for the treatment of primary
myelofibrosis. Five-year safety data showed a higher incidence of skin cancer in patients …

Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre …

SL Barratt, AW Creamer, HI Adamali… - BMJ Open …, 2021 - bmjopenrespres.bmj.com
The factors determining disease course and survival in fibrotic hypersensitivity pneumonitis
(fHP) have not been fully elucidated. The aim of this study was to describe the characteristics …

Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study

J Mandizha, JW Lanario… - BMJ Open …, 2023 - bmjopenrespres.bmj.com
Background Opportunities for home-monitoring are increasing exponentially. Home-
spirometry is reproducible and reliable in interstitial lung disease (ILD), yet patients' …